Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Apatinib Plus Gefitinib As First-Line Treatment in Advanced EGFR-Mutant NSCLC: the Phase III ACTIVE Study (CTONG1706).

Hongyun Zhao,Wenxiu Yao,Xuhong Min,Kangsheng Gu,Guohua Yu,Zhonghan Zhang,Jiuwei Cui,Liyun Miao,Li Zhang,Xia Yuan,Yong Fang,Xiuhua Fu,Chengping Hu,Xiaoli Zhu,Yun Fan,Qitao Yu,Gang Wu,Ou Jiang,Xiuping Du,Jiwei Liu,Wei Gu,Zhiguo Hou,Quanren Wang,Rongrong Zheng,Xianfeng Zhou

Journal of Thoracic Oncology（2021）

Cited 85|Views34
Key words
Non-small cell lung cancer,Epidermal growth factor receptor,Vascular endothelial growth factor,Tar-geted therapy,Apatinib
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined